Ken Griffin Ice Cure Medical Ltd. Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.74 - $1.35 $125,438 - $228,841
169,512 New
169,512 $125,000
Q4 2023

Feb 14, 2024
SELL
$0.72 - $1.36 $15,495 - $29,269
-21,522 Reduced 29.63%
51,112 $54,000
Q3 2023

Nov 14, 2023
BUY
$0.54 - $1.33 $39,222 - $96,603
72,634 New
72,634 $39,000

Others Institutions Holding ICCM

# of Institutions
16
Shares Held
195K
Call Options Held
0
Put Options Held
0
View Full List

About IceCure Medical Ltd.

ICCM Quotes by TradingView
  • Ticker ICCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,835,600
  • Market Cap $41.3M
  • Description
  • IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
More about ICCM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email